ArticleFrontiers in cardiovascular medicine2025
Machine learning-based early warning system for hemodynamic deterioration in cardiovascular ICU patients: a bidirectional cross-validation study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MultiCardioNet: A Multimodal Deep Learning Model for Early Cardiovascular Deterioration Prediction in ICU Patients.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early identification of hemodynamic deterioration in cardiovascular intensive care unit (ICU) patients is critical for improving clinical outcomes. Traditional monitoring approaches and scoring systems often fail to capture dynamic multidimensional physiological changes, and existing machine learning models frequently lack robust external validation across diverse healthcare systems. Methods: We employed a retrospective multi-center cohort design to develop machine learning prediction models using the MIMIC-IV database (46,007 admissions) and the eICU database (50,949 admissions). To rigorously assess model robustness and generalizability, a novel bidirectional cross-validation framework was implemented: models were trained on MIMIC data and validated on eICU data, and conversely, trained on eICU data and validated on MIMIC data. The study defined a strict composite outcome comprising hemodynamic instability, tissue hypoperfusion, and confirmed cardiac etiology. Multiple machine learning algorithms were evaluated to identify the optimal classifier. Results: The Random Forest model was selected as the optimal classifier. Bidirectional validation demonstrated exceptional cross-database generalizability: the MIMIC-trained model achieved an Area Under the Receiver Operating Characteristic (AUROC) of 0.841 on the eICU cohort, while the eICU-trained model achieved an AUROC of 0.852 on the MIMIC cohort, with performance degradation controlled within a minimal range (<4%). DeLong tests confirmed that the model significantly outperformed traditional clinical scores, including SOFA (AUROC 0.681) and APACHE II (AUROC 0.747). The five-level risk stratification system exhibited a strict monotonic increase in mortality rates, ranging from 0.8% in the very low-risk group to 84.2% in the very high-risk group. SHAP analysis identified hemoglobin, history of acute myocardial infarction, and creatinine as the most significant predictors. Conclusions: We successfully developed and validated a machine learning-based early warning system for hemodynamic deterioration in cardiovascular ICU patients. The bidirectional cross-validation approach provides robust evidence for model generalizability, while the multi-level risk stratification system and SHAP-based interpretability offer practical clinical decision support. This system demonstrates significant potential to enhance early identification rates, improve patient outcomes, and optimize healthcare resource utilization efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.